patient monitoring system News
-
West Wireless Health Institute and GE healthcare to collaborate on technology and educational initiatives
West Wireless Health Institute (WWHI) today announced a collaboration with GE Healthcare, a global leader in health care technology, on a variety of research, technology and educational initiatives focused on accelerating wireless health solutions. GE Healthcare has demonstrated innovative leadership in the emerging wireless health industry. WWHI is forging technology and educational partnerships ...
-
THORASYS receives funding aimed at accelerating innovation
THORASYS is pleased to announce that it is receiving advisory services and up to $197,293 in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a research and development project in digital health. Thanks to this support, THORASYS will accelerate a strategic innovation aimed at assessing lung function in remote patient ...
-
The FCC’s COVID-19 Telehealth Program Secures an Additional $250 Million in Funding
What is the COVID-19 Telehealth Program? The FCC launched the COVID-19 Telehealth program as a part of the overarching CARES Act in March 2020 to help nonprofit and public health care providers implement connected care services in response to the COVID-19 pandemic. $200 million dollars in funding was distributed to eligible providers who had qualified for the program via the FCC’s ...
-
Spire Health closes $38 million financing round led by Gilde Healthcare to advance respiratory remote patient monitoring
San Francisco (California, US), Cambridge (Massachusetts, US) –Spire Health, the leading provider of respiratory remote patient monitoring(RPM), today announced the closing of a $38 million equity financing, led by Gilde Healthcare Partners along with a leading global medtech strategic partner. Geoff Pardo, General Partner at Gilde Healthcare, will join Spire’s Board of Directors. ...
By Spire Health
-
CloudCath Announces Collaboration with American Renal Associates in Pre-Market Clinical Study for Peritoneal Dialysis Patients Innovative Remote Monitoring Platform Will Be Tested for In-Home Use
CloudCath, developer of a remote monitoring and predictive analytics platform for catheter-based treatments, today announced a collaboration with American Renal Associates (ARA), a leading provider of outpatient dialysis services. In a U.S.- based, pre-market clinical study, ARA will evaluate the use of CloudCath’s System by peritoneal dialysis (PD) patients. PD is a method of dialysis ...
By CloudCath
-
ZETO: Sensing Improvement in Neurological Data Processing
EEG is the gold standard for observing and characterizing neural activity, but patients are subject to lengthy and uncomfortable preparation for scans, and interpretation is subjective to the physician who reads it. Zeto has introduced a device designed for patient comfort and simple setup, which uses “active” dry electrodes capable of picking up cerebral activity with high digital ...
By Zeto, Inc.
-
How Remote Patient Monitoring Enhances Telehealth
The demand for telehealth in the United States has grown considerably in the past ten years. In 2017, patients were waiting an average of nearly 30 days to see their doctor, whose accessibility is growing increasingly scarce. It’s little wonder that from 2010-2017, the use of telehealth in hospitals increased from 35% to 76%, with nearly every state Medicaid program covering various ...
-
BioIntelliSense Acquires AlertWatch Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions
BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced its acquisition of AlertWatch®, an FDA-cleared, clinically proven patient monitoring solution. AlertWatch uniquely provides robust integration, data analysis and a patented intuitive display of contextual patient data for more efficient, actionable clinical decisions. As part of the recently ...
-
Telehealth is the Rare Healthcare Issue that Enjoys Widespread Support
At first glance, the news that the federal public health emergency will remain in place through the remainder of 2021 might seem like a bad sign for hopes of quickly beating back COVID-19 and finally returning to normal. But it’s also good news for the continued growth of telehealth, and for patients. Norris Cochran, the acting secretary of the U.S. Department of Health and Human ...
-
RemetricHealth’s Integrated Telehealth/Remote Patient Monitoring Solutions Bridge the Gap Between Patients and Providers Amid Ongoing COVID-19 Crisis
RemetricHealth, a leading remote patient monitoring (RPM) and telehealth services company that has been serving the healthcare industry for more than a decade, has announced that its telehealth capabilities, in conjunction with its biometric monitoring devices, are helping connect patients and providers in a time when continuity of care can be challenging due to COVID-19. The telehealth model is ...
-
How Do We Fill The Data Gap In Virtual Care?
Telehealth use skyrocketed in the early months of the Covid-19 pandemic when many health providers were forced to deliver services remotely. Although telehealth visits have dropped from their peak in 2020, they remain elevated even as many patients return to in-person care, according to the results of an analysis by Epic Research and the Kaiser Family Foundation. Survey results show that ...
-
BioIntelliSense Launches Patented, FDA-cleared Pulse Oximetry (SpO2) Sensor Technology that Addresses Skin Pigmentation and Motion Monitoring Challenges
Breakthrough pulse oximetry (SpO2 ) optical sensor solution offers medical-grade accuracy of oxygen level measurement across skin tones and while in motion Patented SpO2 sensor chipset, integrated processing and reference design capability to power the next generation of medical and consumer wearable devices BioIntelliSense, a continuous health monitoring and clinical intelligence company, ...
-
Covid-19 respiratory monitoring with MediPines AGM100
MD Tech Review, a premier medical innovation magazine, has voted MediPines as a 2020 Top Ten Patient Monitoring Solution Provider. MediPines’ innovative respiratory technology, AGM100®, is making a positive impact in hospitals battling Covid-19. This industry recognition came about as MediPines introduced the AGM100®, an advanced respiratory monitoring system, commercially in the ...
By MediPines
-
Nalu Medical Releases “Haleakala” Update, Extending Pulse Width Range and Unlocking the System’s Patient Activity Monitor
Nalu Medical (“NALU”) announces the “Haleakala” update, substantially upgrading both the software and firmware of their award-winning Nalu Neurostimulation System. This update adds significant new capabilities for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). The update broadens the stimulation pulse width parameter to the widest range ...
-
Osprey Introduces DyeVert PLUS at TCT
Osprey Medical (ASX:OSP) is pleased to announce the expansion of its portfolio with introduction of the DyeVert™ PLUS Contrast Modulation/Monitoring System. This new platform integrates the current DyeVert technology with substantial patient management and monitoring capabilities. The system has received European CE Mark and FDA clearance is pending. The Company anticipates US availability ...
-
Bluejay Reports FDA Agrees to Consider its Plan to Pursue a De Novo Regulatory Pathway for the Symphony IL-6 Test
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a medical diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced that the FDA has agreed to consider Bluejay’s plan to pursue a De Novo submission for the Symphony IL-6 Test. In written feedback to the ...
-
Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a medical diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced completion of its previously planned clinical studies for the Symphony IL-6 Test (the “Test”). Results of these studies will be ...
-
Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022
Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical Care Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on developing cost-effective, rapid, ...
-
Saranas® Announces Initial Enrollment of Clinical Trial Assessing the Utility of Early Bleed Detection in Patients Undergoing Mechanical Circulatory Support
Saranas, Inc., has announced initiation and first patient enrollment in SAFE-MCS, a multi-center, single arm, open-label clinical trial evaluating the safety of complex high-risk percutaneous coronary intervention (PCI) using mechanical circulatory support (MCS) and surveillance with the Early Bird Bleed Monitoring System. The first patient was enrolled at Atlantic Health System’s ...
-
Nanox Announces Three Key Senior Level Hires to Support Long-Term Growth Objectives
NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today three senior level additions to the leadership team to further support the Company’s long-term growth objectives. The Company announced that Jim Dara has joined as Chief Operating Officer, Ofir Koren as Chief Technology Officer and Tamar ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you